Rami Suzuki Ph.D. is Senior Group Officer, President, Global Business Development Unit ECL of Eisai Co, Ltd, a multinational pharmaceutical company headquartered in Tokyo. She is responsible for corporate business development, M&A, public-private partnerships and alliance for Japan, Asia and China. After managing a life science venture capital fund for Europe at ITX Corporation, she joined Eisai in 2004. Rami’s lifetime missions are to cure cancer and to prevent dementia.